Co-Authors
This is a "connection" page, showing publications co-authored by Gyorgy Snell and David Veesler.
Connection Strength
2.054
-
Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021 Aug 19; 184(17):4593-4595.
Score: 0.241
-
Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
Score: 0.240
-
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
Score: 0.239
-
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science. 2021 08 06; 373(6555):648-654.
Score: 0.238
-
Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021 06 10; 184(12):3086-3108.
Score: 0.237
-
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 04 29; 184(9):2332-2347.e16.
Score: 0.234
-
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 11 20; 370(6519):950-957.
Score: 0.226
-
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell. 2020 11 12; 183(4):1024-1042.e21.
Score: 0.226
-
Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021 09; 597(7874):103-108.
Score: 0.060
-
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021 05; 593(7857):136-141.
Score: 0.058
-
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
Score: 0.055